Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests - Wall Street Journal

Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests Wall Street Journal ACR scores are a standardized measure of percentage improvement in rheumatoid arthritis signs and symptoms. The most commonly reported side effects were ... New Data for Investigational Antibody Blocking IL-6 in Rheumatoid Arthritis ...MarketWatch (press release) Bristol-Myers says arthritis drug trial met goalReuters RA drug safety trial successfulPharmacy Europe all 110 news articles »

Long-term Cimzia® (certolizumab pegol) Data Demonstrated Rapid Sustained ... - PR Newswire (press release)

Long-term Cimzia® (certolizumab pegol) Data Demonstrated Rapid Sustained ... PR Newswire (press release) Use of TNF blockers, including certolizumab pegol, has been associated with rare cases of new onset or exacerbation of clinical symptoms and/or radiographic ... Two-year Cimzia® (certolizumab pegol) data from study showed sustained ...PR-inside.com (press release) UCB (BE) - Cimzia (certolizumab pegol) shows sustained clinical improvements ...PharmaLive.com (press release) all 9 news articles »

Resveratrol Improves Inflammatory Bowel Disease Symptoms - eMaxHealth

Resveratrol Improves Inflammatory Bowel Disease Symptoms eMaxHealth The inflammatory bowel diseases ulcerative colitis and Crohn's disease affect about 1 million Americans, according to the National Institute of Arthritis ... and more »

Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R ... - PR Newswire (press release)

Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R ... PR Newswire (press release) Horizon's most advanced product is LODOTRA, a circadian cytokine modulator (CCM) for the treatment of the signs and symptoms of rheumatoid arthritis (RA), ... Phase 3 US registration study of LODOTRA shows improvement in patients with RANews-Medical.net all 8 news articles »